Amplified Sciences
Amplified Sciences builds diagnostic tests that detect disease earlier by measuring ultra-low levels of molecular biomarkers. The company uses a proprietary optical reporter platform, BioMatra, combining spectroscopy (including SERS), chemometric analysis, specialized reagents, and machine learning to produce multi-omics and protease-turnover assays. Its lead product, PanCystPro, analyzes pancreatic cyst fluid and the company operates a CLIA-certified lab while positioning the platform for point-of-care scaling. Amplified Sciences targets clinical diagnostics in oncology and chronic disease monitoring and aims to integrate with clinical workflows used by clinicians and diagnostic labs.
Amplified Sciences
Amplified Sciences builds diagnostic tests that detect disease earlier by measuring ultra-low levels of molecular biomarkers. The company uses a proprietary optical reporter platform, BioMatra, combining spectroscopy (including SERS), chemometric analysis, specialized reagents, and machine learning to produce multi-omics and protease-turnover assays. Its lead product, PanCystPro, analyzes pancreatic cyst fluid and the company operates a CLIA-certified lab while positioning the platform for point-of-care scaling. Amplified Sciences targets clinical diagnostics in oncology and chronic disease monitoring and aims to integrate with clinical workflows used by clinicians and diagnostic labs.